Rapid Therapeutic Science Laboratories, Inc. (RTSL)
USD 0.0
(2.56%)
USD 0.0
(2.56%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 1.26 Million USD | -41.8% |
| 2021 | 2.17 Million USD | 0.0% |
| 2019 | 169.69 Thousand USD | 0.0% |
| 2017 | 152.07 Thousand USD | 603.53% |
| 2016 | 21.61 Thousand USD | 79.83% |
| 2015 | 12.02 Thousand USD | -2.3% |
| 2014 | 12.3 Thousand USD | -35.1% |
| 2013 | 18.95 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 103.73 Thousand USD | 5.53% |
| 2023 Q1 | 98.29 Thousand USD | 459.5% |
| 2022 Q1 | 789.39 Thousand USD | 26.97% |
| 2022 Q2 | 128.37 Thousand USD | -83.74% |
| 2022 Q4 | -27.34 Thousand USD | -107.33% |
| 2022 Q3 | 372.9 Thousand USD | 190.48% |
| 2022 FY | 1.26 Million USD | -41.8% |
| 2021 Q2 | 532.8 Thousand USD | 2.47% |
| 2021 Q3 | 496.18 Thousand USD | -6.87% |
| 2021 FY | 2.17 Million USD | 0.0% |
| 2021 Q1 | 519.94 Thousand USD | 0.0% |
| 2021 Q4 | 621.69 Thousand USD | 25.3% |
| 2020 Q2 | 654.51 Thousand USD | 162.6% |
| 2020 Q3 | 620.58 Thousand USD | -5.18% |
| 2020 Q1 | 249.24 Thousand USD | 75.69% |
| 2019 Q4 | 141.86 Thousand USD | 578.59% |
| 2019 Q2 | 22.97 Thousand USD | 17.72% |
| 2019 Q1 | 19.51 Thousand USD | -42.65% |
| 2019 Q3 | 20.9 Thousand USD | -9.0% |
| 2019 FY | 169.69 Thousand USD | 0.0% |
| 2018 Q4 | 34.02 Thousand USD | 39.44% |
| 2018 Q3 | 24.4 Thousand USD | -73.4% |
| 2018 Q2 | 91.74 Thousand USD | -32.22% |
| 2018 Q1 | 135.36 Thousand USD | 2407.17% |
| 2017 Q4 | 5399.00 USD | 74.39% |
| 2017 Q1 | 8770.00 USD | 213.21% |
| 2017 Q2 | 8218.00 USD | -6.29% |
| 2017 FY | 152.07 Thousand USD | 603.53% |
| 2017 Q3 | 3096.00 USD | -62.33% |
| 2016 Q3 | 3365.00 USD | -49.63% |
| 2016 Q4 | 2800.00 USD | -16.79% |
| 2016 FY | 21.61 Thousand USD | 79.83% |
| 2016 Q1 | 3552.00 USD | 7.64% |
| 2016 Q2 | 6681.00 USD | 88.09% |
| 2015 Q4 | 3300.00 USD | 106.9% |
| 2015 Q1 | 1500.00 USD | 0.0% |
| 2015 Q2 | 3573.00 USD | 138.2% |
| 2015 FY | 12.02 Thousand USD | -2.3% |
| 2015 Q3 | 1595.00 USD | -55.36% |
| 2014 Q4 | 1500.00 USD | -1.96% |
| 2014 Q3 | 1530.00 USD | -80.32% |
| 2014 FY | 12.3 Thousand USD | -35.1% |
| 2014 Q2 | 7773.00 USD | 34.85% |
| 2014 Q1 | 5764.00 USD | 16.44% |
| 2013 Q4 | 4950.00 USD | 10.74% |
| 2013 Q2 | 3773.00 USD | 0.0% |
| 2013 FY | 18.95 Thousand USD | 0.0% |
| 2013 Q3 | 4470.00 USD | 18.47% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -70.565% |
| IR-Med Inc. | 4.89 Million USD | 74.186% |
| Polarean Imaging plc | 12.24 Million USD | 89.681% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 4.329% |
| Avitar, Inc. | 3.56 Million USD | 64.608% |
| AVITA Medical, Inc. | 80.77 Million USD | 98.436% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -79.706% |
| Össur hf. | 396.18 Million USD | 99.681% |
| Zecotek Photonics Inc. | 3.46 Million USD | 63.503% |
| QHSLab, Inc. | 961.65 Thousand USD | -31.371% |
| Wellstar International, Inc. | 1.79 Million USD | 29.607% |
| Össur hf. | 396.18 Million USD | 99.681% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 94.199% |
| Escalon Medical Corp. | 5.25 Million USD | 75.94% |
| Aurora Spine Corporation | 8.65 Million USD | 85.408% |
| BrainsWay Ltd. | 28.01 Million USD | 95.491% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 86.791% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 96.237% |
| Vivos Inc. | 2.78 Million USD | 54.672% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.879% |
| Kelyniam Global, Inc. | 2.27 Million USD | 44.475% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -24.478% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -190.088% |
| Nanomix Corporation | 8.36 Million USD | 84.902% |
| Theraclion SA | 7.43 Million USD | 83.019% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | 2.414% |
| Positron Corporation | 1 Million USD | -25.42% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 59.384% |
| Lombard Medical, Inc. | 30.29 Million USD | 95.829% |
| ALR Technologies Inc. | 6.33 Million USD | 80.061% |
| Stratec SE | 46.32 Million USD | 97.273% |
| Vycor Medical, Inc. | 1.27 Million USD | 0.951% |
| Heart Tronics, Inc. | 14.46 Million USD | 91.263% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -948.183% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -512.024% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 91.072% |
| VMS Rehab Systems, Inc. | 63.63 USD | -1985336.115% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 63.832% |
| Ingen Technologies, Inc. | 1.88 Million USD | 32.881% |
| Odyssey Group International, Inc. | -14.26 Million USD | 108.859% |
| United American Healthcare Corporation | 59 Thousand USD | -2041.242% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -210.032% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -99.048% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 25.492% |
| Urologix, Inc. | 10.09 Million USD | 87.482% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 78.761% |
| SS Innovations International, Inc. | 21.38 Million USD | 94.092% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -448.7% |
| Smith & Nephew plc | 3.46 Billion USD | 99.964% |
| NIOX Group Plc | 22.27 Million USD | 94.329% |
| Fuse Medical, Inc. | 10.35 Million USD | 87.794% |
| Broncus Holding Corporation | 38.15 Million USD | 96.689% |
| Brain Scientific Inc. | 9.66 Million USD | 86.926% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 87.738% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -1981.342% |